Big Pharma devising a ‘tit for tat’ strategy
India’s struggle for low cost generic medicines has been ill received by big pharma companies worldwide. India in the past gave a compulsory license to Natco Pharma to produce Bayer AG’s cancer drug Nexavar. This has put companies on the alert – they have been rallying their respective governments to curb export of generics from India and Brazil. Read more here.
Featured Blog Posts
Get The Latest From The Social Sector In Your Inbox!
Subscribe to our newsletter
